The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
1984
DOI: 10.1111/j.1476-5381.1984.tb10133.x
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of s‐ and κ‐ opiate receptor ligands as excitatory amino acid antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
31
0

Year Published

1986
1986
2007
2007

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 83 publications
(31 citation statements)
references
References 18 publications
0
31
0
Order By: Relevance
“…This change, which was seen within 25-60 min of a change to Mg2+-free medium, paralleled changes in the response to NMA (see Fig. 4 (Anis, Burton, Berry & Lodge, 1983) in eight experiments (twenty neurones), cyclazocine (Berry, Dawkins & Lodge, 1984) in six (fifteen neurones) and APV in nine (twenty-eight neurones).…”
Section: Properties Of Recorded Cellsmentioning
confidence: 89%
“…This change, which was seen within 25-60 min of a change to Mg2+-free medium, paralleled changes in the response to NMA (see Fig. 4 (Anis, Burton, Berry & Lodge, 1983) in eight experiments (twenty neurones), cyclazocine (Berry, Dawkins & Lodge, 1984) in six (fifteen neurones) and APV in nine (twenty-eight neurones).…”
Section: Properties Of Recorded Cellsmentioning
confidence: 89%
“…Others have noted that NAM and PCP can inhibit dorsal horn intemeurons (Anis et al, 1983;Berry et al, 1984), and (T binding sites have been demonstrated in the spinal cord (Quirion et al, 198 1;Zukin, 1979, 1981). NAM is a weak analgesic (Martin et al, 1976), but PCP and the related compound, ketamine, are anesthetics.…”
Section: Discussionmentioning
confidence: 99%
“…However, recent radioligand binding studies using the prototypical a ligand, [3H]-( + )-NANM, have demonstrated that (+ )-NANM labels two distinct recognition sites in cerebral membranes: a high affinity site sensitive to nanomolar concentrations of haloperidol and a lower affinity site which corresponds to the recognition site labelled by [3H]-PCP (Zukin & Zukin, 1979;Vincent et al, 1979;Su, 1982;Tam, 1983;Largent et al, 1984;Martin et al, 1984). However, both the benzomorphans and the arylcyclohexylamines are also non-competitive antagonists of the N-methyl-D-aspartic acid (NMDA) receptor (Anis et al, 1983;Berry et al, 1984) and it is not clear which of these properties mediate their psychotomimetic effects.…”
Section: Introductionmentioning
confidence: 99%